FundedStartupsDaily / HealthTech / Adjuvia Therapeutics

Adjuvia Therapeutics raises $8M

Adjuvia Therapeutics announced a Seed round of $8M on 28 July 2026. The company operates in HealthTech and is based in United States. It was founded by Laura Hix Glickman, CEO & Co-Founder.

Raised
$8M
Stage
Seed
Industry
HealthTech
Country
United States

Founder

Laura Hix Glickman
CEO & Co-Founder, Adjuvia Therapeutics
LinkedIn profileadjuvia.com

Outreach angles

  • -Glickman brings more than three decades of drug development experience across oncology, infectious disease, and mitochondrial medicine.
  • -She held prior roles at Selva Therapeutics, Immunitas, and Berkeley SkyDeck.
  • -The $8M Series Seed funds an IND submission for lead candidate ATI-105 and Phase 1 trials starting in Fall 2026.

Signals

SeedHealthcareDeep TechRegulated IndustryB2B

Round details

Company: Adjuvia Therapeutics
Domain: adjuvia.com
Amount: $8M
Stage: Seed
Industry: HealthTech
Country: United States
Announced: 28 July 2026
Source: announcement

Other HealthTech raises

Aignosis
₹4Cr · Seed
Skopos Bio
A$12M · Seed
betterhood
$1.2M · Seed
Herapreg
€215K · Seed
Amethyst Care
€100K · Pre-Seed
Rio Health
$4.5M · Seed

Recently funded in United States

Daptic
$15M · Enterprise Software
Tangent Robotics
$4.5M · Robotics & Hardware
Walapay
$4.6M · FinTech
Destro AI
$8M · Robotics & Hardware
OuterSignal
$22M · AI & Machine Learning
Atomic
$12.5M · Enterprise Software